INNOSPEC INC. (IOSP) FY2025 10-K Annual Report

Filed: Feb 18, 2026
Health Care
Chemicals & Allied ProductsSEC EDGAR

INNOSPEC INC. (IOSP) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 18, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

INNOSPEC INC. FY2025 10-K Analysis

Business Overview

  • Core business: Specialty chemicals for Performance Chemicals, Fuel Specialties, and Oilfield Services segments globally
  • New product emphasis: Innovations in mild surfactants, detergents, cold flow improvers, friction modifiers, biocides, and drilling mud additives
  • Strategic focus: Expanding geographical footprint and pursuing acquisitions to extend technology base and product portfolio
  • Notable metric: R&D spend $51.0M in 2025, down from $56.5M in 2024, supporting new technology development across segments
  • Unique fact: Only global producer of tetra ethyl lead for aviation gasoline marketed as AvGas

Management Discussion & Analysis

  • Revenue $1.778B, down 4% YoY; Performance Chemicals up $27.7M (4%), Fuel Specialties flat, Oilfield Services down $95.5M (19%)
  • Operating income $129.5M vs $177.9M, operating margin 7.3% vs 9.6%; Fuel Specialties best: $144.8M (+12%), Oilfield Services worst: $23.3M (-40%)
  • Gross margin down 1.7 points to 27.7%; Performance Chemicals margin 17.9% vs 22.7%, Fuel Specialties margin up to 36.0% vs 34.2%, Oilfield Services margin down to 29.9% vs 31.5%
  • Cash from operations after capex $63.9M; ended year with $292.5M cash and no debt; dividends up 10% to $1.71/share; repurchased 264K shares for $23.9M
  • 2026 outlook: focus on Performance Chemicals margin recovery, Oilfield Services income growth from Middle East and DRA expansion; Latin America activity not expected to resume

Risk Factors

  • Regulatory risk from U.S. EPA and FAA leaded AvGas phase-out by 2030 risks loss of AvGas income
  • Geopolitical risk from operations in Middle East, Asia-Pacific, Eastern Europe, Latin America with political instability and trade restrictions
  • Operational risk from ongoing multi-year ERP system implementation risking cost overruns, delays, business disruption
  • Competitive risk from larger competitors with better resources and emerging electric/hybrid vehicle technologies reducing gasoline/diesel demand
  • Key-person risk from dependence on senior management and technical staff affecting business continuity if lost

INNOSPEC INC. FY2025 Key Financial Metrics
XBRL

Revenue

$1.8B

-3.7% YoY

Net Income

$117M

+227.5% YoY

Gross Margin

27.7%

-173bp YoY

Operating Margin

7.3%

-236bp YoY

Net Margin

6.6%

+463bp YoY

ROE

8.8%

+585bp YoY

Total Assets

$1.8B

+5.6% YoY

EPS (Diluted)

$4.67

+228.9% YoY

Operating Cash Flow

$138M

-25.0% YoY

Source: XBRL data from INNOSPEC INC. FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on INNOSPEC INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.